News

Filter

Current filters:

PricingZaltrap

NICE final guidance again rejects Sanofi’s Zaltrap for colorectal cancer

25-03-2014

UK drugs watchdog the National Institute for Health and Care Excellence (NICE), today issued final guidance…

Northern EuropeOncologyPharmaceuticalPricingRegulationSanofiUKZaltrap

UK's NICE issues negative new draft guidance on Sanofi's Zaltrap

21-06-2013

The UK's drug watchdog the National Institute for Health Care and Excellence (NICE) has issued new draft…

EuropeOncologyPharmaceuticalPricingRegulationSanofiZaltrap

Sanofi halves US price of Zaltrap, responding to criticism from oncologists

12-11-2012

French drug major Sanofi (Euronext: SAN) has said that it would halve the price of its colorectal cancer…

North AmericaOncologyPharmaceuticalPricingSanofiZaltrap

Back to top